Literature DB >> 4250813

Influence of lidoflazine on cardiac transmembrane potentials and experimental arrhythmias.

E Carmeliet, R Xhonneux.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4250813     DOI: 10.1007/bf01020076

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmakol


× No keyword cloud information.
  26 in total

1.  QUINIDINE SYNCOPE. PAROXYSMAL VENTRICULAR FIBRILLATION OCCURRING DURING TREATMENT OF CHRONIC ATRIAL ARRHYTHMIAS.

Authors:  A SELZER; H W WRAY
Journal:  Circulation       Date:  1964-07       Impact factor: 29.690

2.  THE ACTION OF PAPAVERINE IN CARDIAC ARRHYTHMIAS.

Authors:  I REISER; R E LESLIE
Journal:  Curr Ther Res Clin Exp       Date:  1964-11

3.  QUINIDINE-INDUCED SYNCOPE.

Authors:  P DAVIES; D LEAK; S ORAM
Journal:  Br Med J       Date:  1965-08-28

4.  [Influence of Persantin on the action potential of cat papillary muscle].

Authors:  B PILLAT
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1961

5.  The effects of quinidine, ajmaline, papaverine and adrenergic beta-receptor inhibitors in experimental BaCl2-arrhythmia developed for the quantitative assay of antiarrhythmic drugs.

Authors:  G Papp; L Szekeres; T Szmolenszky
Journal:  Acta Physiol Acad Sci Hung       Date:  1967

6.  Lidoflazine in the treatment of chronic atrial fibrillation.

Authors:  J Piessens; H Kesteloot; H De Geest
Journal:  Arzneimittelforschung       Date:  1970-03

7.  Studies in human atrial flutter with the use of proximity electrodes.

Authors:  Y Kishon; R E Smith
Journal:  Circulation       Date:  1969-10       Impact factor: 29.690

8.  [A new drug for the therapy of angina pectoris and coronary insufficiency: Lidoflazine (R 7904)].

Authors:  K Dziuba
Journal:  Med Welt       Date:  1967-04-08

9.  [The anti-arrythmic effect].

Authors:  L Szekeres
Journal:  Actual Pharmacol (Paris)       Date:  1966

10.  Ionic interconversion of pacemaker and nonpacemaker cultured chick heart cells.

Authors:  N Sperelakis; D Lehmkuhl
Journal:  J Gen Physiol       Date:  1966-05       Impact factor: 4.086

View more
  6 in total

1.  Atrial fibrillation and hyperthyroidism: a new look at their relationship and therapy with lidoflazine.

Authors:  K Bruyneel; H Verhaegen; C De Vil
Journal:  Postgrad Med J       Date:  1975-01       Impact factor: 2.401

2.  Effects on infarct size of reperfusion and pretreatment with beta-blockade and calcium antagonists.

Authors:  S Torr; A J Drake-Holland; M Main; J Hynd; K Isted; M I Noble
Journal:  Basic Res Cardiol       Date:  1989 Nov-Dec       Impact factor: 17.165

3.  Comparison of lidoflazine and quindine in prophylactic treatment of arrhythmias.

Authors:  B M Kennelly
Journal:  Br Heart J       Date:  1977-05

4.  Lidoflazine in the early stages of acute myocardial ischaemia.

Authors:  S J Coker; O Fagbemi; J R Parratt
Journal:  Br J Pharmacol       Date:  1982-06       Impact factor: 8.739

Review 5.  Withdrawal of prenylamine: perspectives on pharmacological, clinical and regulatory outcomes following the first QT-related casualty.

Authors:  Rashmi R Shah; Peter D Stonier
Journal:  Ther Adv Drug Saf       Date:  2018-06-18

6.  Effects of the local anesthetics brufacain and lidocaine on transmembrane action potentials, refractory period, and reactivation of the sodium system in guinea pig heart muscle.

Authors:  H Iven; H Brasch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-03       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.